2025. The effectiveness of semaglutida in preventing cardiovascular risks associated with obesity and diabetes. Revista Eletrônica Acervo Médico. 25, (Oct. 2025), e21868. DOI:https://doi.org/10.25248/reamed.e21868.2025.